"Studio NaVA" - National Study on Quality of Life in Adolescents Affected by Allergic Rhinitis With or Without Asthma

Stefania La Grutta, MD1,200 enrolled

Overview

"Studio Nava" is a National Study aiming to assess allergic rhinitis and asthma outcomes on Quality of Life and Quality of Sleep in adolescent patients by means of Web Survey. "Studio Nava" also proposes the innovative use of a web platform ("http://nava.ibim.cnr.it/") that contains all standardized tools (medical-healthcare web form, ACT, Asthma control test; PSQI, Pittsburgh Sleep Quality Index; T5SS, Total Symptom Score; modified SIDRIA for adolescents; Rhinasthma; VAS scale), that will be available for the doctors after the registration to the web platform. Downloaded questionnaires will be delivered to case-patient, asking him/her to fill them during the waiting time of the visit.

Study Type

OBSERVATIONAL

Enrollment

1,200

Conditions

Allergic Rhinitis Asthma

Interventions

Data CollectionOTHER

Eligibility

Medical Language ↔ Plain English

Inclusion Criteria: * Clinical cases n°: 600 adolescents affected by allergic rhinitis with/without asthma, from 14 to 17 years age. * Controls n°: 600 subject (5 for each participant Pediatrician) of the same age range, without respiratory pathology. Exclusion Criteria: * Subjects that have not allergic rhinitis with/without asthma diagnosis or are \<14 years old or \>17 years old

Locations (2)

Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council

Palermo, Sicily, Italy

Institute of Biomedicine and Molecular Immunology, IBIM

Palermo, Italy

Outcomes

Primary Outcomes

Assessment of the allergic rhinitis impact on quality of life

Time frame: 2 weeks

Secondary Outcomes

The impact of AR and asthma on quality of sleep

Time frame: 2 weeks